To examine, how the perturbation of FLT3-ITD+ AML-specific modules that are not shared with healthy cells would affect the viability of primary FLT3-ITD+ AML cells, we examined the crosstalk between selected TF modules by genome-wide analyses. The gene discussed is FLT3; the disease is acute myeloid leukemia.